Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin as Adjuvant Therapy in Colorectal Cancer Patients Undergoing FOLFIRI
NCT03130634Phase 4Completed
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Apr 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of silymarin in chemotherapy-induced gastrointestinal toxicity, sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Started Apr 2016; status: completed.
02
Drugs
silymarin
03
Conditions
chemotherapy-induced gastrointestinal toxicity
Beyond the preview
Go deeper on NCT03130634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03130634.